Supporting Innovation in Life Sciences IP
P&TS is actively engaged in intellectual property protection across the life sciences, pharmaceutical, and biotech sectors. As the regulatory landscape continues to evolve and innovation accelerates in these fields, robust IP strategy has become essential for companies navigating complex market dynamics.
The 2026 ExEx Forum, now in its 16th edition on May 28, brings together professionals from the pharma, biotech, and medtech ecosystem to discuss key industry developments including regulatory frameworks, clinical innovation, digital transformation, and emerging technologies. For organizations like P&TS working at the intersection of IP and life sciences innovation, this represents a valuable forum for meaningful exchange with stakeholders across the sector.
By sponsoring the ExEx Forum, P&TS reinforces its commitment to supporting the life sciences and biotech community. We believe that fostering professional dialogue around the strategic challenges facing this ecosystem, including IP considerations, contributes to a more informed and resilient industry.
We look forward to participating in the discussions and connecting with peers navigating the evolving landscape of innovation in life sciences and pharma.
